ATNF
Price
$1.07
Change
-$0.01 (-0.93%)
Updated
May 8 closing price
Capitalization
6.11M
GLMD
Price
$1.25
Change
-$0.04 (-3.10%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
2.82M
Ad is loading...

ATNF vs GLMD

Header iconATNF vs GLMD Comparison
Open Charts ATNF vs GLMDBanner chart's image
180 Life Sciences
Price$1.07
Change-$0.01 (-0.93%)
Volume$43.69K
Capitalization6.11M
Galmed Pharmaceuticals
Price$1.25
Change-$0.04 (-3.10%)
Volume$3.11K
Capitalization2.82M
ATNF vs GLMD Comparison Chart
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. GLMD commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a Hold and GLMD is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ATNF: $1.07 vs. GLMD: $1.25)
Brand notoriety: ATNF and GLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 26% vs. GLMD: 13%
Market capitalization -- ATNF: $6.11M vs. GLMD: $2.82M
ATNF [@Biotechnology] is valued at $6.11M. GLMD’s [@Biotechnology] market capitalization is $2.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whileGLMD’s FA Score has 0 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • GLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, GLMD is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 6 TA indicator(s) are bullish while GLMD’s TA Score has 4 bullish TA indicator(s).

  • ATNF’s TA Score: 6 bullish, 4 bearish.
  • GLMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATNF is a better buy in the short-term than GLMD.

Price Growth

ATNF (@Biotechnology) experienced а -19.32% price change this week, while GLMD (@Biotechnology) price change was -2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

ATNF is expected to report earnings on Mar 31, 2025.

GLMD is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNF($6.11M) has a higher market cap than GLMD($2.82M). ATNF has higher P/E ratio than GLMD: ATNF (0.13) vs GLMD (0.02). ATNF YTD gains are higher at: -41.038 vs. GLMD (-59.561). ATNF has higher annual earnings (EBITDA): -2.99M vs. GLMD (-6.7M). GLMD has more cash in the bank: 17.1M vs. ATNF (195K). GLMD has less debt than ATNF: GLMD (41K) vs ATNF (3.26M). ATNF (0) and GLMD (0) have equivalent revenues.
ATNFGLMDATNF / GLMD
Capitalization6.11M2.82M217%
EBITDA-2.99M-6.7M45%
Gain YTD-41.038-59.56169%
P/E Ratio0.130.02652%
Revenue00-
Total Cash195K17.1M1%
Total Debt3.26M41K7,941%
FUNDAMENTALS RATINGS
ATNF vs GLMD: Fundamental Ratings
ATNF
GLMD
OUTLOOK RATING
1..100
1039
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
6065
P/E GROWTH RATING
1..100
9696
SEASONALITY SCORE
1..100
454

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (41) in the Pharmaceuticals Other industry is in the same range as ATNF (56) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

GLMD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

GLMD's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as ATNF (96) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

ATNF's Price Growth Rating (60) in the Financial Conglomerates industry is in the same range as GLMD (65) in the Pharmaceuticals Other industry. This means that ATNF’s stock grew similarly to GLMD’s over the last 12 months.

ATNF's P/E Growth Rating (96) in the Financial Conglomerates industry is in the same range as GLMD (96) in the Pharmaceuticals Other industry. This means that ATNF’s stock grew similarly to GLMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNFGLMD
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REAX4.470.24
+5.67%
Real Brokerage (The)
EWBC87.400.76
+0.88%
East West Bancorp
KRMD2.72-0.02
-0.73%
KORU Medical Systems
SGBX0.40-0.02
-4.61%
Safe & Green Holdings Corp.
APLS17.99-1.13
-5.91%
Apellis Pharmaceuticals

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
-0.64%
PRQR - ATNF
54%
Loosely correlated
-1.27%
KRRO - ATNF
44%
Loosely correlated
+10.55%
WVE - ATNF
42%
Loosely correlated
+0.77%
JSPR - ATNF
41%
Loosely correlated
+2.55%
BDRX - ATNF
39%
Loosely correlated
+2.17%
More